Advertisement
Screener

ARS Pharmaceuticals, Inc. (SPRY) ROE

ARS Pharmaceuticals, Inc. (SPRY) ROE

  • 2026-06-30: ROE -1721.80%.
  • 2026-03-31: ROE -322.92%.
  • 2025-12-31: ROE -149.92%.
  • 2025-09-30: ROE -54.21%.

Complete source-backed roe history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-1721.80%
2026-03-31-322.92%
2025-12-31-149.92%
2025-09-30-54.21%
2025-06-30-24.97%
2025-03-31-6.83%
2024-12-313.11%
2024-09-30-24.43%
2024-06-30-20.83%
2024-03-31-22.20%
2023-12-31-23.56%
2023-09-30-25.97%
2023-06-30-21.46%
2023-03-31-16.23%
2022-12-31-12.71%
2022-09-30-50.89%
2022-06-30-21.46%
2022-03-3122.55%
2021-12-3164.74%
2021-09-30-23.82%
2021-06-30-18.47%
2021-03-31-12.63%
2020-12-31234.46%

Annual ROE

DateROE
2025-12-31-149.92%
2024-12-313.11%
2023-12-31-23.56%
2022-12-31-12.71%
2021-12-3164.74%
2020-12-31234.46%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85